PRAH PRA Health Sciences, Inc. gains 15% Jun 9, 2020

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. The company offers integrated services, such as data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It also provides product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. The company's services also comprise strategic solutions comprising embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services consisting of Phase I through Phase IIa studies and bioanalytical laboratory services. It conducts clinical trials in the areas of pharmaceutical development, including oncology, central nervous system, inflammation, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. The company was founded in 1976 and is headquartered in Raleigh, North Carolina.http://www.priceseries.com/trade/PRAH-PRA-Health-Sciences-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020051420200609.html